• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肠神经内分泌癌的双灶复发:一例报告

Bilocal recurrence of a neuroendocrine carcinoma of the small intestine: A case report.

作者信息

Peiffer S, Cathomas R, Villiger P

机构信息

Department of General Surgery, Kantonsspital Graubünden, Loestrasse 170, CH-7000 Chur, Switzerland.

Department of Oncology, Kantonsspital Graubünden, Loestrasse 170, CH-7000 Chur, Switzerland.

出版信息

Int J Surg Case Rep. 2014;5(12):1117-9. doi: 10.1016/j.ijscr.2014.11.004. Epub 2014 Nov 10.

DOI:10.1016/j.ijscr.2014.11.004
PMID:25437652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4275779/
Abstract

INTRODUCTION

Neuroendocrine tumors of the small intestine represent about half of all small intestine neoplasms. Recurrence after surgery with curative intention is frequently observed but recurrence rate has not yet been described or analyzed sufficiently.

PRESENTATION OF CASE

In this case bilocal recurrence 4 years after curative surgery of an ileocoecal neuroendocrine carcinoma was observed in a 64 year old female. Diagnosis and follow-up was carried out as proposed in current ENETS guidelines using somatostatin receptor scintigraphy for primary diagnosis and Ga-DOTATOC-PET/CT in follow-up.

DISCUSSION

We can confirm that PET/CT for somatostatin receptor imaging shows good sensitivity in detecting neuroendocrine neoplasms and should be preferred for diagnostic, if available. For individual adaptation of follow-up procedures, as far as time intervals and preferred imaging methods are concerned, research on recurrence rate and long term outcome after curative surgery should be extended.

CONCLUSION

Livelong follow-up after surgical resection of neuroendocrine tumors is necessary and Ga-DOTA/TOC-PET/CT should be the method of choice, if available.

摘要

引言

小肠神经内分泌肿瘤约占所有小肠肿瘤的一半。根治性手术后复发较为常见,但复发率尚未得到充分描述或分析。

病例介绍

该病例为一名64岁女性,在回盲部神经内分泌癌根治性手术后4年出现双部位复发。按照当前ENETS指南的建议进行诊断和随访,使用生长抑素受体闪烁扫描进行初步诊断,随访时使用镓- DOTATOC - PET/CT。

讨论

我们可以确认,用于生长抑素受体成像的PET/CT在检测神经内分泌肿瘤方面具有良好的敏感性,如有条件,应优先用于诊断。就随访程序的个体化调整而言,涉及时间间隔和首选成像方法,应扩大对根治性手术后复发率和长期预后的研究。

结论

神经内分泌肿瘤手术切除后需要长期随访,如有条件,镓- DOTA/TOC - PET/CT应作为首选方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4921/4275779/bcd85e5ef120/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4921/4275779/39e4c7c72772/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4921/4275779/488d1a42c9d1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4921/4275779/f1cb7c1c6946/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4921/4275779/bcd85e5ef120/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4921/4275779/39e4c7c72772/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4921/4275779/488d1a42c9d1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4921/4275779/f1cb7c1c6946/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4921/4275779/bcd85e5ef120/gr4.jpg

相似文献

1
Bilocal recurrence of a neuroendocrine carcinoma of the small intestine: A case report.小肠神经内分泌癌的双灶复发:一例报告
Int J Surg Case Rep. 2014;5(12):1117-9. doi: 10.1016/j.ijscr.2014.11.004. Epub 2014 Nov 10.
2
Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.神经内分泌肿瘤患者的骨转移:68Ga-DOTA-酪胺酸3-奥曲肽PET与CT及骨闪烁显像的比较
J Nucl Med. 2009 Aug;50(8):1214-21. doi: 10.2967/jnumed.108.060236. Epub 2009 Jul 17.
3
Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.(68)Ga-DOTA-TOC PET/CT用于检测MEN1患者十二指肠胰腺神经内分泌肿瘤的评估
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1258-66. doi: 10.1007/s00259-016-3319-3. Epub 2016 Jan 28.
4
68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy.68Ga-DOTA-酪氨酰3-奥曲肽PET用于评估生长抑素受体介导的放射性核素治疗的反应。
J Nucl Med. 2009 Sep;50(9):1427-34. doi: 10.2967/jnumed.108.053421. Epub 2009 Aug 18.
5
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.68Ga-DOTA-酪氨酰3-奥曲肽PET在神经内分泌肿瘤中的应用:与生长抑素受体闪烁扫描及CT的比较
J Nucl Med. 2007 Apr;48(4):508-18. doi: 10.2967/jnumed.106.035667.
6
Intraoperative somatostatin receptor detection after peptide receptor radionuclide therapy with (177)Lu- and (90)Y-DOTATOC (tandem PRRNT) in a patient with a metastatic neuroendocrine tumor.肽受体放射性核素治疗(使用¹⁷⁷Lu和⁹⁰Y-DOTATOC进行串联肽受体放射性核素治疗)后,对一名转移性神经内分泌肿瘤患者进行术中生长抑素受体检测。
Recent Results Cancer Res. 2013;194:487-96. doi: 10.1007/978-3-642-27994-2_28.
7
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
8
Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.使用[68Ga]-DOTA-D Phe(1)-Tyr(3)-奥曲肽的正电子发射断层扫描成像与[111In]-DTPA-奥曲肽单光子发射计算机断层扫描的比较评估。神经内分泌肿瘤患者的初步结果。
Mol Imaging Biol. 2003 Jan-Feb;5(1):42-8. doi: 10.1016/s1536-1632(03)00038-6.
9
Preliminary PET/CT Imaging with Somatostatin Analogs [Ga]DOTAGA-TATE and [Ga]DOTAGA-TOC.采用生长抑素类似物[Ga]DOTAGA-TATE 和 [Ga]DOTAGA-TOC 的初步 PET/CT 成像。
Mol Imaging Biol. 2017 Dec;19(6):878-884. doi: 10.1007/s11307-017-1072-z.
10
Ga-DOTATOC PET/CT in the localization of head and neck paraganglioma compared with F-DOPA PET/CT and I-MIBG SPECT/CT.镓-DOTATOC PET/CT 对头颈部副神经节瘤的定位与 F-DOPA PET/CT 和 I-MIBG SPECT/CT 的比较。
Nucl Med Biol. 2019 Apr;71:47-53. doi: 10.1016/j.nucmedbio.2019.04.003. Epub 2019 Apr 29.

本文引用的文献

1
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.神经内分泌肿瘤复发:68Ga-DOTATATE PET/CT 诊断。
Radiology. 2014 Feb;270(2):517-25. doi: 10.1148/radiol.13122501. Epub 2013 Oct 28.
2
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas.ENETS空肠、回肠和阑尾神经内分泌肿瘤(包括杯状细胞癌)患者管理共识指南
Neuroendocrinology. 2012;95(2):135-56. doi: 10.1159/000335629. Epub 2012 Feb 15.
3
Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.胃肠胰神经内分泌肿瘤:基于世界卫生组织和欧洲神经内分泌肿瘤学会分类的当前发病率和分期:基于前瞻性收集参数的分析。
Endocr Relat Cancer. 2010 Oct 5;17(4):909-18. doi: 10.1677/ERC-10-0152. Print 2010 Dec.
4
Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.(68)镓-多柔比星-酪氨酰(3)-奥曲肽与(18)氟-氟-L-二羟基苯丙氨酸正电子发射断层扫描在神经内分泌肿瘤患者中的比较
Q J Nucl Med Mol Imaging. 2010 Feb;54(1):68-75.
5
Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.多期 68Ga-DOTATOC-PET/CT 对神经内分泌肿瘤患者治疗管理的影响。
Neuroendocrinology. 2010;91(1):101-9. doi: 10.1159/000265561. Epub 2009 Dec 9.
6
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation.神经内分泌肿瘤护理标准的ENETS共识指南:随访与记录
Neuroendocrinology. 2009;90(2):227-33. doi: 10.1159/000225952. Epub 2009 Aug 28.
7
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.胃肠胰神经内分泌肿瘤长期预后的预测因素
Endocr Relat Cancer. 2008 Dec;15(4):1083-97. doi: 10.1677/ERC-08-0017. Epub 2008 Jul 4.
8
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.“类癌”百年之后:美国35825例神经内分泌肿瘤的流行病学及预后因素
J Clin Oncol. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377.
9
Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.使用68Ga-DOTATATE(DOTA-DPhe1,Tyr3-奥曲肽)和18F-FDG联合PET/CT对神经内分泌肿瘤进行功能成像。
Cancer. 2008 Jun;112(11):2447-55. doi: 10.1002/cncr.23469.
10
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.68Ga-DOTA-酪氨酰3-奥曲肽PET在神经内分泌肿瘤中的应用:与生长抑素受体闪烁扫描及CT的比较
J Nucl Med. 2007 Apr;48(4):508-18. doi: 10.2967/jnumed.106.035667.